Search Prime Grants

U54CA096300

Cooperative Agreement

Overview

Grant Description
UPRCCC/MDACC: PARTNERSHIP FOR EXCELLENCE IN CANCER RESEARCH
Awardee
The Univeristy Of Texas M.D. Anderson Cancer Center
Funding Goals
TO PROVIDE AN ORGANIZATIONAL FOCUS AND STIMULUS FOR THE HIGHEST QUALITY CANCER RESEARCH THAT EFFECTIVELY PROMOTES INTERDISCIPLINARY CANCER RESEARCH AIMED TOWARD THE ULTIMATE GOAL OF REDUCING CANCER INCIDENCE, MORTALITY AND MORBIDITY. THE CANCER CENTER SUPPORT GRANT (CCSG) PROVIDES THE RESOURCES AND INFRASTRUCTURE TO FACILITATE THE COORDINATION OF INTERDISCIPLINARY PROGRAMS ACROSS A BROAD SPECTRUM OF RESEARCH FROM BASIC LABORATORY RESEARCH TO CLINICAL INVESTIGATION TO POPULATION SCIENCE. THE CCSG SUPPORTS SALARIES FOR SCIENTIFIC LEADERSHIP OF THE CENTER, SHARED RESOURCES FOR FUNDED CENTER INVESTIGATORS, CERTAIN ADMINISTRATIVE COSTS, PLANNING AND EVALUATION, AND DEVELOPMENTAL FUNDS FOR NEW RECRUITMENTS AND FEASIBILITY STUDIES.
Grant Program (CFDA)
93.397 - Cancer Centers Support Grants
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
Texas United States
Geographic Scope
State-Wide
Related Opportunity
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional) (PAR-18-767)
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/30/13 to 08/31/26 and the total obligations have increased 3721% from $454,836 to $17,378,306.
The Univeristy Of Texas M.D. Anderson Cancer Center was awarded UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2) Cooperative Agreement U54CA096300 worth $17,378,306 from National Cancer Institute in August 2002 with work to be completed primarily in Texas United States. The grant has a duration of 24 years and was awarded through assistance program 93.397 Cancer Centers Support Grants. The Cooperative Agreement was awarded through grant opportunity Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 9/5/25

Period of Performance
8/16/02
Start Date
8/31/26
End Date
96.0% Complete

Funding Split
$17.4M
Federal Obligation
$0.0
Non-Federal Obligation
$17.4M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U54CA096300

Subgrant Awards

Disclosed subgrants for U54CA096300

Transaction History

Modifications to U54CA096300

Additional Detail

Award ID FAIN
U54CA096300
SAI Number
U54CA096300-1567479919
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NC00 NIH National Cancer Institute
Awardee UEI
S3GMKS8ELA16
Awardee CAGE
0KD38
Performance District
TX-90
Senators
John Cornyn
Ted Cruz

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $7,630,950 100%
Modified: 9/5/25